By the third day, the dizziness had made it impossible for me to walk unaided. I couldn’t sit upright without toppling over.

A novel blood-based test for early detection of colorectal cancer in average-risk adults met the primary endpoints of sensitivity and specificity in the PREEMPT CRC trial.

"Seeing is believing," the founder of lab company Truvian told me. So I tried its tabletop blood testing device—which promises results in 30 minutes—for myself.

Slowly, Amanda Bradford walked the trails of Oroville’s Loafer Creek Recreation Area on Wednesday afternoon as she carefully guided a white flag along the grass and foxtails beside her hunting for ...

Two U.S. companies teamed up to treat cancer patients using an unproven blood filter in Antigua, out of reach of American ...

About half of U.S. adults have high blood pressure, a major risk for heart attacks, strokes, kidney failure, even dementia.

Sepsis, the leading cause of death in U.S. hospitals killing about 350,000 people annually, is an extreme response to an ...

A new way of interpreting standard blood tests could help doctors spot cancer warning signs sooner, according to scientists.

The Galleri test — which isn’t covered by insurance — doesn’t come cheap. At $949 a pop, it’s out of the price range of most ...

Researchers at Oregon Health & Science University have uncovered how a molecule found on certain bacteria may drive blood ...

In vivo perturbations and single-cell RNA-seq reveal cell-type-specific STAT1-IFNg signaling in regulation of trained immunity in tissue-resident immune cells.

At-home test kits offer a convenient way to monitor health conditions privately, using advanced technologies for accurate and ...